<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02838173</url>
  </required_header>
  <id_info>
    <org_study_id>B406201628750</org_study_id>
    <nct_id>NCT02838173</nct_id>
  </id_info>
  <brief_title>Serratus Plane Block for the Prevention of Chronic Pain After Breast Cancer Surgery</brief_title>
  <official_title>Serratus Plane Block for the Prevention of Chronic Pain After Breast Cancer Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasme University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erasme University Hospital</source>
  <brief_summary>
    <textblock>
      This study compare the &quot;Serratus block plane&quot; (SPB) and the local infiltration of the tissue
      in the prevention of acute and chronic pain after breast cancer surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic pain after breast surgery may be severe, often requiring the use of morphine. The
      incidence of chronic pain varies from 27 to 50% depending on definitions.

      The infiltration of tissues by a local anesthetic is a simple, fast and low risk technique
      but of limited effectiveness.

      Serratus the flat block, performed under ultrasound guidance, is minimally invasive and easy
      to perform. It allows anesthesia and analgesia to an extended part of the anterolateral chest
      wall and the axilla. This regional anesthesia technique provides good analgesia during and
      after breast surgery, but remains to be evaluated; beyond perioperative analgesia, the
      benefit-risk, post operative rehabilitation, and the impact on ambulatory and on chronic pain
      are fundamental objectives.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative chronic pain assessed using the DN4 questionnaire</measure>
    <time_frame>3 months postoperative</time_frame>
    <description>DN4 questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative acute pain</measure>
    <time_frame>day 1, day 2, day 3 postoperative</time_frame>
    <description>Visual analogue scale (V.A.S.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>morphine consumption</measure>
    <time_frame>day 1, day 2, day 3 postoperative</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>length of stay in the Postoperative Acute Care Unit</measure>
    <time_frame>through study completion</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>length of stay in hospital</measure>
    <time_frame>through study completion</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Breast/Surgery</condition>
  <condition>Postoperative Complication</condition>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>SPB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Serratus Plane Bloc with Ropivacaine 2mg/ml (0,3ml/kg) and tissue infiltration with placebo made once, by the anesthetist in the operating theater before surgical incision</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tissue infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>tissue infiltration with Ropivacaine 2mg/ml (0,3ml/kg) and Serratus Plane Bloc with placebo made once, by the anesthetist in the operating theater before surgical incision</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>serratus plane bloc : Ropivacaine 2mg/ml (0,3ml/kg)</intervention_name>
    <arm_group_label>SPB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>tissue infiltration : Ropivacaine 2mg/ml (0,3ml/kg)</intervention_name>
    <arm_group_label>tissue infiltration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>serratus plane bloc : placebo</intervention_name>
    <arm_group_label>tissue infiltration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>tissue infiltration : placebo</intervention_name>
    <arm_group_label>SPB</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women scheduled for elective breast neoplasm surgery

          -  Of ASA classification 1, 2 or 3

          -  Patients who provide written informed consent

        Exclusion Criteria:

          -  Minor patients

          -  Patients refusing to sign the consent

          -  Patients included in another protocol within 3 months

          -  Pregnant or lactating patients

          -  Patients with history of allergy to local anesthetics (Ropivacaine)

          -  Patients with contraindication to regional anesthesia (coagulopathy, local infection
             ...)

          -  Patients with history of prior breast surgery (excluding diagnostic biopsy)

          -  Patients with history of chronic pain

          -  Patients with a history of psychiatric disorder
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luc Van Obbergh, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Erasme Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Céline Boudart, MD</last_name>
    <phone>3225553919</phone>
    <email>cboudart@ulb.ac.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wendy Villareal Fernandez, MD</last_name>
  </overall_contact_backup>
  <reference>
    <citation>Blanco R, Parras T, McDonnell JG, Prats-Galino A. Serratus plane block: a novel ultrasound-guided thoracic wall nerve block. Anaesthesia. 2013 Nov;68(11):1107-13. doi: 10.1111/anae.12344. Epub 2013 Aug 7.</citation>
    <PMID>23923989</PMID>
  </reference>
  <reference>
    <citation>Andreae MH, Andreae DA. Regional anaesthesia to prevent chronic pain after surgery: a Cochrane systematic review and meta-analysis. Br J Anaesth. 2013 Nov;111(5):711-20. doi: 10.1093/bja/aet213. Epub 2013 Jun 28. Review.</citation>
    <PMID>23811426</PMID>
  </reference>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2016</study_first_submitted>
  <study_first_submitted_qc>July 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2016</study_first_posted>
  <last_update_submitted>July 19, 2016</last_update_submitted>
  <last_update_submitted_qc>July 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erasme University Hospital</investigator_affiliation>
    <investigator_full_name>Céline Boudart</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

